Expression of the c-met proteins in malignant skin cancers

Annals of Dermatology

Volumn 23, Issue 1, 2011, Pages 33-38

  Lee, Yoon Jin ^a   Kim, Dae Hyun ^b   Lee, Sang Han ^a   Kim, Dong Wook ^a   Nam, Hae Seon ^a   Cho, Moon Kyun ^a,b  

^a Soonchunhyang University   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

Author keywords

C Met expression; Hepatocyte growth factor (hgf); Skin cancers

Indexed keywords

EID: 79955606614     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.1.33     Document Type: Article

References (34)

1. Wolf HK, Zarnegar R, Michalopoulos GK. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 1991; 14: 488-494.
2. Wang Y, Selden AC, Morgan N, Stamp GW, Hodgson HJ. Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol 1994; 144: 675-682. (Pubitemid 24172056)
3. Michalopoulos GK, Zarnegav R. Hepatocyte growth factor. Hepatology 1992; 15: 149-155.
4. Peruzzi B, Bottaro DP. Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 2006; 12: 3657-3660.
5. Pisters LL, Trancoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW. c-Met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 1995; 154: 293-298.
6. Matteucci E, Bendinelli P, Desiderio MA. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells. Carcinogenesis 2009; 30: 937-945.
7. Gomes DA, Rodrigues MA, Leite MF, Gomez MV, Varnai P, Balla T, et al. c-Met must translocate to the nucleus to initiate calcium signals. J Biol Chem 2008; 283: 4344-4351.
8. Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF. Met expression and sarcoma tumorigenicity. Cancer Res 1993; 53: 5355-5360.
9. Prat M, Narsimhan RP, Crepaldi T, Nicotra MR, Natali PG, Comoglio PM. The receptor encoded by the human c-Met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 323-328.
10. Sheth PR, Watowich SJ. Biochemical ground-rules regulating c-Met receptor tyrosine kinase activation and signaling. Cancer Ther 2006; 4: 1-12.
11. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984; 311: 29-33.
12. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993; 55: 72-75. (Pubitemid 23261709)
13. Natali PG, Nicotra MR, Di Renzo MF, Prat M, Bigotti A, Cavaliere R, et al. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br J Cancer 1993; 68: 746-750.
14. Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, et al. Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer 1994; 58: 658-662.
15. Boix L, Rosa JL, Ventura F, Castells A, Bruix J, Rodés J, et al. c-met mRNA overexpression in human hepatocellular carcinoma. Hepatology 1994; 19: 88-91.
16. Belfiore A, Gangemi P, Costantino A, Russo G, Santonocito GM, Ippolito O, et al. Negative/low expression of the Met/ hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab 1997; 82: 2322-2328.
17. Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008; 7: 504-516. (Pubitemid 351767118)
18. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH. c-Met proto-oncogene expression in benign and malignant human renal tissues. J Urol 1997; 158: 724-728.
19. Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, et al. Overexpression of the met/HGF receptor in renal cell carcinomas. Int J Cancer 1996; 69: 212-217.
20. Wagatsuma S, Konno R, Sato S, Yajima A. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 1998; 82: 520-530.
21. Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT, et al. Hepatocyte growth factor and its receptor (c-Met) in prostatic carcinoma. Am J Pathol 1995; 147: 386-396.
22. Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 1997; 25: 862-866. (Pubitemid 27157127)
23. Berchuck A, Soisson AP, Clarke-Pearson DL, Soper JT, Boyer CM, Kinney RB, et al. Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential. Cancer Res 1989; 49: 2091-2095.
24. Aasmundstad TA, Haugen OA, Johannesen E, Høe AL, Kvinnsland S. Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods. J Clin Pathol 1992; 45: 125-129.
25. Ersoy B, Ozbilgin K, Kasirga E, Inan S, Coskun S, Tuglu I. Effect of growth hormone on small intestinal homeostasis relation to cellular mediators IGF-1 and IGFBP-3. World J Gastroenterol 2009; 15: 5418-5424.
26. Ma PC, Maulik G, Christensen J, Salgia R. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev 2003; 22: 309-325.
27. Duh FM, Scherer SW, Tsui LC, Lerman Ml, Zbar B, Schmidt L. Gene structure of the human MET proto-oncogene. Oncogene 1997; 15: 1583-1586.
28. Boccaccio C, Comoglio PM. Invasive growth: a Met-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6: 637-645.
29. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met protooncogene product. Biochim Biophys Acta 1993; 1155: 357-371. (Pubitemid 24012300)
30. Chung LW, Li W, Gleave ME, Hsieh JT, Wu HC, Sikes RA, et al. Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem Suppl 1992; 16H: 99-105.
31. Scarpino S, Stoppacciaro A, Colarossi C, Cancellario F, Marzullo A, Marchesi M, et al. Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid. J Pathol 1999; 189: 570-575.
32. Corso S, Migliore C, Ghiso E, De Rosa G, Comoglio PM, Giordano S. Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene 2008; 27: 684-693.
33. Beviglia L, Matsumoto K, Lin CS, Ziober BL, Kramer RH. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int J Cancer 1997; 74: 301-309. (Pubitemid 27321800)
34. Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, et al. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 1997; 76: 339-353.